New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

The German Center for Neurodegenerative Diseases (DZNE) is investing approximately six million euros to establish a one-of-a-kind global genome database. The digital library, known as “NeuroGenomeHub,” aims to drive research into neurodegenerative diseases like Alzheimer’s, Parkinson’s, ALS, FTD, and Huntington’s. The project plans to capture the genetic information of about 25,000 people over the next two years.

Researchers at Marshall University have identified a potential immune mechanism contributing to metabolic dysfunction and insulin resistance associated with obstructive sleep apnea (OSA), offering new insight into how chronic sleep-related oxygen deprivation affects overall health.

The world’s first HIV-positive-to-HIV-positive lung transplant was performed at NYU Langone Health. The surgery brings new hope for HIV-positive patients in need of lung transplants, as it opens a pool of potential donors who were previously ineligible.

New antibiotic candidates for drug-resistant bacteria may reside inside prions, mis-folded protein in the brain best known for rare and fatal degenerative brain diseases. Prion and prion-like proteins may hide short peptides, named “prionins,” that can kill bacteria, suggesting proteins best known for their role in neurodegeneration may contain molecular features linked to immune defense, according to new research from the Perelman School of Medicine at the University of Pennsylvania.